Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...
Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...
“This is how viruses evolve. It is not surprising that SARS-CoV2 has become very weak now. It would probably still not be ...
The following is a summary of "Early bacterial co-infections and ventilator-associated lower respiratory tract infections ...
Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...
People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback